Report updated May 8, 2026
MHApp - Malignant Hyperthermia
For medical professionals and students seeking to train for malignant hyperthermia management.
Overview · Full Intel report in progress
MHApp - Malignant Hyperthermia is an established medical app that is completely free. With a 4.1/5 rating from 9 reviews, it shows polarized user reception.
What is MHApp - Malignant Hyperthermia?
Current Momentum
v2.4
No release notes available.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Guides users through simulated malignant hyperthermia scenarios to practice acute management.
Automatically records actions and injected medication doses during the simulated crisis.
Provides instructions for managing acidosis, hyperkalemia, and dosing for dantrolene or ryanodex.
How much does it cost?
Who Built It?
Girard Development
Providing specialized medical reference tools to assist healthcare professionals in clinical decision-making. These apps offer guidance on medication management and emergency protocols for perioperative care.
Portfolio
3
Apps
What other apps does Girard Development make?
Explore the full Girard Development report
Portfolio breakdown, audience, momentum, and every app published by Girard Development.
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for MHApp - Malignant Hyperthermia?
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
2 active rankings tracked — 30-day window
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for MHApp - Malignant Hyperthermia
Key Takeaways
This app is marketed as an educational tool for training purposes and is not intended to serve as a substitute for professional medical advice.
Where Is It Heading?
Trend analysis
Available very soon